Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to evaluate the safety and efficacy of rhEGF
(recombinant human Epidermal Growth Factor) in diabetic foot ulcer patients with uncontrolled
diabetes mellitus.